Search research articles
Contact Us
Filters
Showing results (11-20 of 329) with videos related to
Page
of 33
Sort By:
Statistics in Medicine
|
October 15, 2014
A principal stratification approach for evaluating natural direct and indirect effects in the presence of treatment-induced intermediate confounding
Masataka Taguri, Yasutaka Chiba
Statistical Methods in Medical Research
|
April 28, 2025
Partial areas under the curve of the cumulative distribution function as a new composite estimand for randomized clinical trials
Masataka Taguri, Kenichi Hayashi
Plos One
|
December 22, 2023
Epidemiology of cruciate ligament surgery in Japan: A repeated cross-sectional study from 2014 to 2021
Shota Uchino, Masataka Taguri
Statistical Methods in Medical Research
|
November 25, 2015
Causal mediation analysis with multiple causally non-ordered mediators
Masataka Taguri, John Featherstone, Jing Cheng
Biometrical Journal. Biometrische Zeitschrift
|
May 13, 2022
gBOIN-ET: The generalized Bayesian optimal interval design for optimal dose-finding accounting for ordinal graded efficacy and toxicity in early clinical trials
Kentaro Takeda, Satoshi Morita, Masataka Taguri
Biometrical Journal. Biometrische Zeitschrift
|
May 27, 2024
Valid instrumental variable selection method using negative control outcomes and constructing efficient estimator
Shunichiro Orihara, Atsushi Goto, Masataka Taguri
Biometrics
|
March 14, 2014
Model selection criterion for causal parameters in structural mean models based on a quasi-likelihood
Masataka Taguri, Yutaka Matsuyama, Yasuo Ohashi
JRSM Short Reports
|
December 10, 2013
Relative age effect on Nobel laureates in the UK
Hisanori Fukunaga, Masataka Taguri, Satoshi Morita
Pharmaceutical Statistics
|
April 28, 2018
BOIN-ET: Bayesian optimal interval design for dose finding based on both efficacy and toxicity outcomes
Kentaro Takeda, Masataka Taguri, Satoshi Morita
Pharmaceutical Statistics
|
December 13, 2019
TITE-BOIN-ET: Time-to-event Bayesian optimal interval design to accelerate dose-finding based on both efficacy and toxicity outcomes
Kentaro Takeda, Satoshi Morita, Masataka Taguri
Page
of 33
Search research articles
Search
Showing results (11-20 of 329) with videos related to
Sort By:
Page
of 33
Statistics in Medicine
|
October 15, 2014
A principal stratification approach for evaluating natural direct and indirect effects in the presence of treatment-induced intermediate confounding
Masataka Taguri, Yasutaka Chiba
Statistical Methods in Medical Research
|
April 28, 2025
Partial areas under the curve of the cumulative distribution function as a new composite estimand for randomized clinical trials
Masataka Taguri, Kenichi Hayashi
Plos One
|
December 22, 2023
Epidemiology of cruciate ligament surgery in Japan: A repeated cross-sectional study from 2014 to 2021
Shota Uchino, Masataka Taguri
Statistical Methods in Medical Research
|
November 25, 2015
Causal mediation analysis with multiple causally non-ordered mediators
Masataka Taguri, John Featherstone, Jing Cheng
Biometrical Journal. Biometrische Zeitschrift
|
May 13, 2022
gBOIN-ET: The generalized Bayesian optimal interval design for optimal dose-finding accounting for ordinal graded efficacy and toxicity in early clinical trials
Kentaro Takeda, Satoshi Morita, Masataka Taguri
Biometrical Journal. Biometrische Zeitschrift
|
May 27, 2024
Valid instrumental variable selection method using negative control outcomes and constructing efficient estimator
Shunichiro Orihara, Atsushi Goto, Masataka Taguri
Biometrics
|
March 14, 2014
Model selection criterion for causal parameters in structural mean models based on a quasi-likelihood
Masataka Taguri, Yutaka Matsuyama, Yasuo Ohashi
JRSM Short Reports
|
December 10, 2013
Relative age effect on Nobel laureates in the UK
Hisanori Fukunaga, Masataka Taguri, Satoshi Morita
Pharmaceutical Statistics
|
April 28, 2018
BOIN-ET: Bayesian optimal interval design for dose finding based on both efficacy and toxicity outcomes
Kentaro Takeda, Masataka Taguri, Satoshi Morita
Pharmaceutical Statistics
|
December 13, 2019
TITE-BOIN-ET: Time-to-event Bayesian optimal interval design to accelerate dose-finding based on both efficacy and toxicity outcomes
Kentaro Takeda, Satoshi Morita, Masataka Taguri
Page
of 33